It is too cheap based on its earnings and potential earnings I hope the independent report recommends a higher price. Waiken
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025